In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing

Gabriel Courties(Harvard University), Timo Heidt(Harvard University), Matthew Sebas(Harvard University), Yoshiko Iwamoto(Harvard University), Derrick Jeon(Harvard University), Jessica Truelove(Harvard University), Benoit Tricot(Harvard University), Gregory R. Wojtkiewicz(Harvard University), Partha Dutta(Harvard University), Hendrik B. Sager(Harvard University), Anna Borodovsky(Alnylam Pharmaceuticals (United States)), Tatiana I. Novobrantseva(Alnylam Pharmaceuticals (United States)), Boris Klebanov(Alnylam Pharmaceuticals (United States)), Kevin Fitzgerald(Alnylam Pharmaceuticals (United States)), Daniel G. Anderson(Massachusetts Institute of Technology), Peter Libby(Brigham and Women's Hospital), Filip K. Świrski(Harvard University), Ralph Weissleder(Harvard University), Matthias Nahrendorf(Harvard University)
Journal of the American College of Cardiology
December 19, 2013
Cited by 278Open Access
Full Text

Abstract


Related Papers